 Drugs in Dev.
 Drugs in Dev.								 Musculoskeletal
Musculoskeletal
											 Preclinical
Preclinical
											
																			 United Kingdom
United Kingdom								
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : RMD 1101
Therapeutic Area : Musculoskeletal
Study Phase : Preclinical
Sponsor : Tufts University
Deal Size : Undisclosed
Deal Type : Agreement
Remedium Bio Announces Research Agreement with a Leading Rheumatology Laboratory
Details : Through this partnership, Remedium aims to characterize the functionality of its lead candidate RMD 1101, in a range of in vitro, ex vivo, and in vivo efficacy models that will help to advance it toward IND.
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Undisclosed
September 15, 2021
Lead Product(s) : RMD 1101
Therapeutic Area : Musculoskeletal
Highest Development Status : Preclinical
Sponsor : Tufts University
Deal Size : Undisclosed
Deal Type : Agreement


 
															 Reset All
Reset All